|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sleeman JP, Nazarenko I and Thiele W: Do
all roads lead to Rome? Routes to metastasis development. Int J
Cancer. 128:2511–2526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition-A hallmark of breast cancer metastasis. Cancer Hallm.
1:38–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bogenrieder T and Herlyn M: Axis of evil:
Molecular mechanisms of cancer metastasis. Oncogene. 22:6524–6536.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davis FM, Stewart TA, Thompson EW and
Monteith GR: Targeting EMT in cancer: Opportunities for
pharmacological intervention. Trends Pharmacol Sci. 35:479–488.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ginnebaugh KR, Ahmad A and Sarkar FH: The
therapeutic potential of targeting the epithelial-mesenchymal
transition in cancer. Expert Opin Ther Targets. 18:731–745. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ali NA, Lüdtke J, Pilgrim H and Lindequist
U: Inhibition of chemiluminescence response of human mononuclear
cells and suppression of mitogen-induced proliferation of spleen
lymphocytes of mice by hispolon and hispidin. Pharmazie.
51:667–670. 1996.PubMed/NCBI
|
|
14
|
Huang GJ, Deng JS, Chiu CS, Liao JC, Hsieh
WT, Sheu MJ and Wu CH: Hispolon protects against acute liver damage
in the rat by inhibiting lipid peroxidation, proinflammatory
cytokine and oxidative stress and downregulating the expressions of
iNOS, COX-2 and MMP-9. Evid Based Complement Alternat Med.
2012:4807142012.PubMed/NCBI
|
|
15
|
Yang LY, Shen SC, Cheng KT, Subbaraju GV,
Chien CC and Chen YC: Hispolon inhibition of inflammatory apoptosis
through reduction of iNOS/NO production via HO-1 induction in
macrophages. J Ethnopharmacol. 156:61–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen W, Zhao Z, Li L, Wu B, Chen SF, Zhou
H, Wang Y and Li YQ: Hispolon induces apoptosis in human gastric
cancer cells through a ROS-mediated mitochondrial pathway. Free
Radic Biol Med. 45:60–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YC, Chang HY, Deng JS, Chen JJ, Huang
SS, Lin IH, Kuo WL, Chao W and Huang GJ: Hispolon from Phellinus
linteus induces G0/G1 cell cycle arrest and apoptosis in NB4
human leukaemia cells. Am J Chin Med. 41:1439–1457. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YS, Lee SM, Lin CC and Liu CY:
Hispolon decreases melanin production and induces apoptosis in
melanoma cells through the downregulation of tyrosinase and
microphthalmia-associated transcription factor (MITF) expressions
and the activation of caspase-3, −8 and −9. Int J Mol Sci.
15:1201–1215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang GJ, Deng JS, Huang SS and Hu ML:
Hispolon induces apoptosis and cell cycle arrest of human
hepatocellular carcinoma Hep3B cells by modulating ERK
phosphorylation. J Agric Food Chem. 59:7104–7113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu TL, Huang GJ, Lu TJ, Wu JB, Wu CH, Yang
TC, Iizuka A and Chen YF: Hispolon from Phellinus linteus
has antiproliferative effects via MDM2-recruited ERK1/2 activity in
breast and bladder cancer cells. Food Chem Toxicol. 47:2013–2021.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Derynck R, Muthusamy BP and Saeteurn KY:
Signaling pathway cooperation in TGF-β-induced
epithelial-mesenchymal transition. Curr Opin Cell Biol. 31:56–66.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Drabsch Y and ten Dijke P: TGF-β
signalling and its role in cancer progression and metastasis.
Cancer Metastasis Rev. 31:553–568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fabregat I, Fernando J, Mainez J and
Sancho P: TGF-beta signaling in cancer treatment. Curr Pharm Des.
20:2934–2947. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mulholland DJ, Kobayashi N, Ruscetti M,
Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK
activation cooperate to promote EMT and metastasis initiated from
prostate cancer stem/progenitor cells. Cancer research.
72:1878–1889. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Principe DR, Doll JA, Bauer J, Jung B,
Munshi HG, Bartholin L, Pasche B, Lee C and Grippo PJ: TGF-β:
Duality of function between tumor prevention and carcinogenesis. J
Natl Cancer Inst. 106:djt3692014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jang EH, Jang SY, Cho IH, Hong D, Jung B,
Park MJ and Kim JH: Hispolon inhibits the growth of estrogen
receptor positive human breast cancer cells through modulation of
estrogen receptor alpha. Biochem Biophys Res Commun. 463:917–922.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim JH, Kim YC and Park B: Hispolon from
Phellinus linteus induces apoptosis and sensitizes human
cancer cells to the tumor necrosis factor-related
apoptosis-inducing ligand through upregulation of death receptors.
Oncol Rep. 35:1020–1026. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Araki K, Shimura T, Suzuki H, Tsutsumi S,
Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin
switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Z, Zhang L, Ma Z, Yang M, Tang J, Fu Y,
Mao Y, Hong X and Zhang Y: ETV1 induces epithelial to mesenchymal
transition in human gastric cancer cells through the upregulation
of Snail expression. Oncol Rep. 30:2859–2863. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Masui T, Ota I, Yook JI, Mikami S, Yane K,
Yamanaka T and Hosoi H: Snail-induced epithelial-mesenchymal
transition promotes cancer stem cell-like phenotype in head and
neck cancer cells. Int J Oncol. 44:693–699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and De Herreros García A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang MH, Wu MZ, Chiou SH, Chen PM, Chang
SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by
HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen ZF and Behringer RR: Twist is
required in head mesenchyme for cranial neural tube morphogenesis.
Genes Dev. 9:686–699. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
